Also known as Cetrimide, Cetrimoni Bromidum and Tetradecyl trimethyl ammonium bromide (TTAB), FeF® Strong Cetrimide Solution 40% BP Pharma with isopropyl alcohol (CAS No. 1119-97-7) consists of around 20% dodecyl trimethyl ammonium bromide and approcimately 80% trimethyl tetradecyl ammonium bromide, as well as approximately 7.5% volume by volume (v/v) isopropyl alcohol.

Manufactured to meet current good manufacturing practice (cGMP) guideline ICH Q7 for Active Pharmaceutical Ingredients, FeF® is analysed according to the current British Pharmacopoeia (BP) requirements.

Packaging sizes:

  • Item number: 7800025, 200kg drum

Documentation and services

Novo Nordisk Pharmatech provides a wide range of documentation, including:

  • European drug master file (ASMF)
  • Good manufacturing practice (GMP) certificate
  • Certificate of Analysis (current version of Pharmacopoeia)
  • Datasheets
  • Customer audits
  • Stability results
  • Declarations and statements such as transmissible spongiform encephalopathy (TSE) / bovine spongiform encephalopathy (BSE) statements, residual solvents, genetically modified organism (GMO), allergens and animal testing
  • Reach
  • Change notification statement
  • Pre-filled supplier questionnaires
  • Impurity profile
  • Description of the manufacturing process
  • Process flowchart
  • Packaging details
  • Quality agreements